NEUPHORIA THERAPEUTICS INC (NEUP) Stock Income Statement
USA - NASDAQ:NEUP - US64136E1029 - Common Stock
6.24 USD
+2.19 (+54.07%)
5.9104 USD
-0.33 (-5.28%)
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.65M | 0.00 | 0.00 | 191.00K | 0.00 | |||
| Operating Expenses | 16.78M | 17.89M | 21.98M | 16.34M | 6.47M | |||
| Research and Development | 9.01M | 9.42M | 13.07M | 11.60M | 4.30M | |||
| Selling, General, and Administrative Expenses | 7.77M | 8.47M | 8.91M | 8.26M | 5.41M | |||
| Operating Income | -1.13M | -17.89M | -21.98M | -16.15M | -6.47M | |||
| Interest Income/Expense | -249.00K | 10.00K | 632.00K | 246.00K | -65.00K | |||
| Other Income/Expense | 540.00K | 2.30M | 423.00K | -13.00K | -201.00K | |||
| Non Recurring Items | N/A | N/A | -593.00K | 0.00 | 128.00K | |||
| Income Before Taxes | -838.00K | -15.58M | -21.52M | -15.92M | -6.63M | |||
| Income Tax | -468.00K | -87.00K | -139.00K | -139.00K | -140.00K | |||
| Net Income | -370.00K | -15.49M | -21.38M | -15.78M | -6.49M | |||
| EBITDA | -466.10K | -17.23M | -21.32M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.23 | -0.10 | -0.17 | -0.14 | -0.10 | |||
| Non GAAP EPS | N/A | N/A | N/A | -0.02 | -0.01 | |||
| Statistics | ||||||||
| Profit Margin | -2.36% | N/A | N/A | -8260.21% | N/A | |||
| Operating Profit Margin | -7.21% | N/A | N/A | -8454.45% | N/A | |||
All data in USD